The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Iricryn 0.3 mg/ml eye drops, solution

Farmaprojects S.A.PA1391/006/001

Main Information

Trade NameIricryn 0.3 mg/ml eye drops, solution
Active SubstancesBimatoprost
Dosage FormEye drops, solution
Licence HolderFarmaprojects S.A.
Licence NumberPA1391/006/001

Group Information

ATC CodeS01EE03 bimatoprost


License statusAuthorised
Licence Issued09/09/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back